ArticleFrontiers in endocrinology2025
Association between metabolic activity of visceral adipose tissue and retinal vein occlusion: a preliminary
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Obesity and Eye Diseases.Nutrients · 2026Review
- Systemic metabolic dysfunction is associated with local treatment failure: the role of visceral adiposity index in anti-VEGF resistance in diabetic macular edema.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Retinal vein occlusion (RVO) predominantly occurs in individuals over the age of 50, and obesity is a recognized risk factor for its development. The pro-inflammatory metabolic activity of visceral adipose tissue (VAT), which elevates systemic inflammation, is regarded as a key underlying mechanism contributing to the detrimental effects of obesity on atherosclerosis and hypercoagulability in RVO. In this study, we aimed to evaluate the inflammatory metabolic activity of VAT using Material and methods: A total of 22 elderly patients with RVO (aged ≥ 50 years) who underwent Results: The VAT SUVmax was higher in patients with RVO compared to the non-RVO group. Additionally, levels of systemic inflammation surrogate markers were elevated in patients with RVO relative to those without RVO. Furthermore, VAT SUVmax showed a positive correlation with systemic inflammation surrogate markers and was independently associated with the presence of RVO. Conclusions: The metabolic activity of VAT, as assessed by
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.